Burgess B Freeman Selected Research

Burgess B Freeman Research Topics

Disease

20	Neoplasms (Cancer) 04/2024 - 01/2006
5	Medulloblastoma 01/2023 - 04/2006
4	Leukemia 11/2021 - 01/2021
4	Brain Neoplasms (Brain Tumor) 01/2018 - 01/2006
4	Ependymoma 01/2018 - 05/2015
3	Neuroblastoma 03/2024 - 01/2006
2	Muscular Atrophy (Muscle Atrophy) 01/2024 - 01/2018
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2023 - 01/2021
2	Malaria 06/2022 - 01/2020
2	Rhabdoid Tumor (Rhabdoid Tumors) 01/2020 - 11/2006
2	Infections 01/2020 - 04/2004
2	Choroid Plexus Carcinoma 01/2018 - 01/2016
2	Rhabdomyosarcoma 01/2017 - 01/2006
2	Osteosarcoma (Osteogenic Sarcoma) 05/2014 - 01/2006
2	Wilms Tumor (Wilm's Tumor) 07/2007 - 01/2006
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 03/2024
1	Cytopenia 03/2024
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 11/2023
1	Genomic Instability 10/2023
1	Cardiotoxicity 11/2021
1	Coinfection 10/2021
1	Human Influenza (Influenza) 10/2021
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2021
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2020
1	Motor Neuron Disease (Primary Lateral Sclerosis) 01/2018
1	Atrophy 01/2018
1	Central Nervous System Neoplasms 04/2016
1	Retinoblastoma (Glioblastoma, Retinal) 11/2014
1	Body Weight (Weight, Body) 05/2014
1	Vomiting 11/2006

Drug/Important Bio-Agent (IBA)

3	Topotecan (Hycamtin)FDA LinkGeneric 11/2007 - 04/2006
2	Proteins (Proteins, Gene)FDA Link 04/2024 - 10/2021
2	Furylfuramide (AF2)IBA 01/2024 - 01/2018
2	Androgen Receptors (Androgen Receptor)IBA 01/2024 - 01/2018
2	Gemcitabine FDA Link 01/2021 - 04/2014
2	Vincristine (Oncovin)FDA LinkGeneric 01/2021 - 01/2017
2	LactonesIBA 11/2007 - 04/2006
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 06/2007 - 11/2006
2	Histone Deacetylase InhibitorsIBA 08/2006 - 01/2006
2	DepsipeptidesIBA 08/2006 - 01/2006
1	CCS1477IBA 04/2024
1	N- (3- chloro- 7- indolyl)- 1,4- benzenedisulphonamide (E7070)IBA 03/2024
1	Adrenergic Agents (Adrenergic Drugs)IBA 03/2024
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2024
1	CytokinesIBA 03/2024
1	ruxolitinibIBA 03/2024
1	gamma-delta T-Cell Antigen Receptors (T-Cell Receptor delta-Chain)IBA 11/2023
1	V 70 (V70)IBA 11/2023
1	AZD1390IBA 10/2023
1	MTOR InhibitorsIBA 01/2023
1	Retinoblastoma ProteinIBA 01/2023
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2023
1	Drug CombinationsIBA 01/2023
1	ribociclibIBA 01/2023
1	Antiparasitic Agents (Antiparasitics)IBA 06/2022
1	CX 5461IBA 11/2021
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 11/2021
1	RNA (Ribonucleic Acid)IBA 11/2021
1	Topoisomerase I InhibitorsIBA 11/2021
1	Antiviral Agents (Antivirals)IBA 10/2021
1	baloxavirIBA 10/2021
1	AerosolsIBA 10/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Decitabine FDA Link 01/2021
1	Dasatinib (BMS 354825)FDA Link 01/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2021
1	talazoparibIBA 01/2021
1	HomoharringtonineIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	SJ733IBA 01/2020
1	Antimalarials (Antimalarial Agents)IBA 01/2020
1	ProteomeIBA 10/2018
1	AndrogensIBA 01/2018
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 01/2018
1	adavosertibIBA 01/2017
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2017
1	Oxidoreductases (Dehydrogenase)IBA 04/2016
1	Coenzyme A (CoA)IBA 04/2016
1	Simvastatin (Zocor)FDA LinkGeneric 04/2016
1	Hydroxy AcidsIBA 04/2016
1	NucleosidesIBA 01/2016
1	TetrahydrouridineIBA 01/2016
1	5-fluoro-2'-deoxycytidineIBA 01/2016
1	Clofarabine (Clolar)FDA Link 05/2015
1	2'-deoxyadenosineIBA 05/2015
1	SuspensionsIBA 11/2014
1	ProdrugsIBA 11/2014
1	EmulsionsIBA 11/2014
1	Syk KinaseIBA 11/2014
1	Bevacizumab (Avastin)FDA Link 05/2014
1	Pemetrexed (MTA)FDA Link 04/2014
1	Carbamazepine (Tegretol)FDA LinkGeneric 06/2007

Therapy/Procedure

11	Therapeutics 03/2024 - 04/2014
4	Drug Therapy (Chemotherapy) 01/2018 - 10/2006
2	Immunotherapy 03/2024 - 11/2021
1	Aftercare (After-Treatment) 11/2021
1	Radiotherapy 01/2018
1	Topical Administration 11/2014
1	Intravitreal Injections 11/2014